Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Novel high risk genes of melanoma

Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia
Novel high risk genes of melanoma ( Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia )
18 May 2017

New insights in Merkel cell biology and treatment

Dr Paul Nghiem - University of Washington, Seattle, USA
New insights in Merkel cell biology and treatment ( Dr Paul Nghiem - University of Washington, Seattle, USA )
18 May 2017

Duration of checkpoint inhibitor therapy

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Duration of checkpoint inhibitor therapy ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
17 May 2017

PD1/ CTLA4 : Upfront or sequentially?

Prof Christoph Höller - Medical University of Vienna, Vienna, Austria
PD1/ CTLA4 : Upfront or sequentially? ( Prof Christoph Höller - Medical University of Vienna, Vienna, Austria )
17 May 2017

Brain metastases: a role of conventional chemotherapy?

Dr Peter Mohr - Elbe Klinikum Buxtehude, Germany
Brain metastases: a role of conventional chemotherapy? ( Dr Peter Mohr - Elbe Klinikum Buxtehude, Germany )
17 May 2017

New imaging approaches for the diagnosis of melanoma and skin cancer

Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain
New imaging approaches for the diagnosis of melanoma and skin cancer ( Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain )
17 May 2017

Editor's Choice for April 2017

Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for April 2017 ( Prof Gordon McVie - Editor in Chief, ecancer )
28 Apr 2017

Novel bi-specific TCR-based reagents for targeted cancer immunotherapy

Dr Joseph Dukes - Immunocore Limited, Abingdon, UK
Novel bi-specific TCR-based reagents for targeted cancer immunotherapy ( Dr Joseph Dukes - Immunocore Limited, Abingdon, UK )
27 Apr 2017

Pembrolizumab and indoximod for melanoma

Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA
Pembrolizumab and indoximod for melanoma ( Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA )
13 Apr 2017

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA
Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030 ( Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA )
12 Apr 2017

Avelumab for metastatic Merkel cell carcinoma after chemotherapy

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Avelumab for metastatic Merkel cell carcinoma after chemotherapy ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )
12 Apr 2017

Nivolumab and ipilimumab combination for advanced skin cancer

Dr James Larkin - The Royal Marsden, London, UK
Nivolumab and ipilimumab combination for advanced skin cancer ( Dr James Larkin - The Royal Marsden, London, UK )
12 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation